Hansa Medical holds 5 712 161 shares in Genovis AB (publ.) as a strategic investment. The placement is equivalent to 10 % of the outstanding shares of Genovis. Genovis is a biotechnology company focused on protein engineering tools based on the enzymes IdeS and EndoS. These products facilitate development and quality control of antibody based drugs. Genovis' shares are traded on NASDAQ OMX First North, by the ticker symbol GENO.